Literature DB >> 16205510

Decreased prevalence of nonalcoholic fatty liver disease in black obese children.

Miriam V Louthan1, Judy A Theriot, Ellen Zimmerman, John T Stutts, Craig J McClain.   

Abstract

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) is a common cause of pediatric liver disease. Studies suggest decreased prevalence in blacks, females, and younger children. However, the proportion of black subjects in these studies was small, and children under 12 were not included. We propose that abnormal alanine aminotransferase (ALT) is more common in whites than blacks, males than females, and children over 12 compared with younger children in a prospective study.
METHODS: We enrolled 181 consecutive asymptomatic obese children attending general pediatric clinics who denied recent fever or known liver disease. Obesity was defined as body mass index (BMI) z score of greater than 1.64 (95th percentile for age and sex). Elevated ALT was defined as greater than 40 U/L. BMI z score, race, sex, age, and parental obesity were compared using the chi-square test and Fisher's exact test.
RESULTS: The population included 81 males and 100 females, 147 non-Hispanic black, 33 non-Hispanic white, and 1 Hispanic white. Elevated ALT occurred in 14 (8%) subjects. White children were significantly more likely to have abnormal ALT (odds ratio [OR] = 4.0, P < .02). Very obese children (BMI z score >2.3) were more likely to have abnormal ALT compared with mildly obese children (OR = 4.0, P < 0.05). Sex, age, hepatomegaly, acanthosis nigricans, and parental obesity did not significantly predict elevated ALT.
CONCLUSION: Eight percent of asymptomatic, obese children had an elevated ALT suggestive of NAFLD. White and very obese children are more likely to be affected. Sex and age are not good clinical predictors of NAFLD. We suggest that all obese children be screened for NAFLD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205510     DOI: 10.1097/01.mpg.0000177314.65824.4d

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  27 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.

Authors:  Eric R Kallwitz; Mrudula Kumar; Radhika Aggarwal; Reed Berger; Jennifer Layden-Almer; Neil Gupta; Scott J Cotler
Journal:  Dig Dis Sci       Date:  2008-03-18       Impact factor: 3.199

Review 3.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Nutrition and nonalcoholic fatty liver disease in children.

Authors:  Miriam B Vos; Craig J McClain
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

5.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

6.  Keratin 18, Apoptosis, and Liver Disease in Children.

Authors:  Yanci O Mannery; Craig J McClain; Miriam B Vos
Journal:  Curr Pediatr Rev       Date:  2011-11

Review 7.  Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children.

Authors:  Monica M Betancourt-Garcia; Armando Arguelles; Jorge Montes; Ambrosio Hernandez; Manish Singh; R Armour Forse
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

8.  Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.

Authors:  Miriam B Vos; Shirish Barve; Swati Joshi-Barve; John D Carew; Peter F Whitington; Craig J McClain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-10       Impact factor: 2.839

9.  Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.

Authors:  Diana R Mager; Simon Ling; Eve A Roberts
Journal:  Paediatr Child Health       Date:  2008-02       Impact factor: 2.253

10.  Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.

Authors:  Perrie E Pardee; Joel E Lavine; Jeffrey B Schwimmer
Journal:  Semin Pediatr Surg       Date:  2009-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.